Pharmaceuticals Egypt

Egypt Direct-to-Consumer Genetic Testing Market Analysis, 2024–2034

Egypt Direct-to-Consumer Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Egypt · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.9 Mn Estimated value
Estimate 2025 $6.7 Mn 0.3% of the global market
Projected 2034 $21.1 Mn 215.1% Adds $14.4 Mn over 9 forecast years
CAGR 2025–2034 13.6% Faster than 68% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Egypt is 0.27% of the global market.
  • In Africa, the largest is South Africa at $16.8 Mn.
  • Fastest growing: Egypt (this report) at 13.6% a year.
  • Egypt ranks 2nd of 3 by size in Africa.

Market size projection

Egypt

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$14.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Direct-to-Consumer Genetic Testing Market market size by year, Egypt
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.9 Mn — —
2025 (base) $6.7 Mn +$0.8 Mn —
2026 (forecast) $7.6 Mn +$0.9 Mn +13.6%
2027 (forecast) $8.7 Mn +$1.0 Mn +29%
2028 (forecast) $9.8 Mn +$1.2 Mn +46.6%
2029 (forecast) $11.2 Mn +$1.3 Mn +66.5%
2030 (forecast) $12.7 Mn +$1.5 Mn +89.2%
2031 (forecast) $14.4 Mn +$1.7 Mn +114.9%
2032 (forecast) $16.4 Mn +$2.0 Mn +144.1%
2033 (forecast) $18.6 Mn +$2.2 Mn +177.3%
2034 (forecast) $21.1 Mn +$2.5 Mn +215.1%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.51 Bn
  2. North America $1.26 Bn
  3. US $891.5 Mn
  4. APAC $592.2 Mn
  5. Europe $423.3 Mn
  6. China $210.6 Mn
  7. Canada $196.9 Mn
  8. Japan $142.5 Mn
  9. Middle East $115.7 Mn
  10. Latin America $111.7 Mn
  11. Germany $96.0 Mn
  12. France $72.4 Mn
  13. Brazil $72.3 Mn
  14. UK $64.0 Mn
  15. Italy $64.6 Mn
  16. Spain $48.0 Mn
  17. India $51.2 Mn
  18. Ecuador $45.9 Mn
  19. Saudi Arabia $46.3 Mn
  20. Africa $40.7 Mn
  21. Mexico $39.5 Mn
  22. Australia $29.5 Mn
  23. New Zealand $28.6 Mn
  24. Russia $24.2 Mn
  25. South Africa $16.8 Mn
  26. UAE $13.5 Mn
  27. Egypt (this report) $6.7 Mn
  28. Philippines $4.9 Mn
  29. Hong Kong $4.7 Mn
  30. Malaysia $4.0 Mn
  31. Thailand $2.8 Mn
  32. Singapore $2.6 Mn
  33. Kenya $2.0 Mn

The Egypt Direct-to-Consumer Genetic Testing Market Analysis Executive Summary

Direct-to-consumer genetic tests are bought online by individuals to learn about ancestry, traits and some health risks from a saliva sample.

Key segments of the direct-to-Consumer Genetic Testing market include test (Ancestry, Health Risk and Carrier Status) and channel (Online and Retail).

Egypt Direct-to-Consumer Genetic Testing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the direct-to-Consumer Genetic Testing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the direct-to-Consumer Genetic Testing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the direct-to-Consumer Genetic Testing market.

Competitive Landscape for Direct-to-Consumer Genetic Testing Market in Egypt

The direct-to-Consumer Genetic Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Direct-to-Consumer Genetic Testing Market in Egypt

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for direct-to-Consumer Genetic Testing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Egypt.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Direct-to-Consumer Genetic Testing right now, from free public sources.

Latest research 144 papers since 2021 (worldwide)

  1. Misattributed Paternity: Why Truth Must be Pursued. Journal of bioethical inquiry, 2026
  2. Bridging the BRCA1/2 variant previvor gap in health care. JAAPA : official journal of the American Academy of Physician Assistants, 2026
  3. Private information leakage from polygenic risk scores. Genome research, 2026
  4. Experiences of insemination fraud: discovering and navigating unexpected and entangled connections. Human fertility (Cambridge, England), 2026
  5. Common Single Nucleotide Polymorphisms in Clinical Cardiology and Dietary Intervention: A Narrative Review. Nutrients, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Direct-to-Consumer Genetic Testing in context

Egypt compared

  • Health spending per person: 141 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 17 countries we cover in Africa.[1]
  • Doctors: 0.67 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 3rd highest of the 17 countries we cover in Africa.[2]
  • People aged 65 and over: 5.3% of people (2025). World: 10.4% of people (2025). 3rd highest of the 17 countries we cover in Africa.[3]

Questions, answered with public data

How much research is published on Direct-to-Consumer Genetic Testing?
PubMed lists 144 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Direct-to-Consumer Genetic Testing in Egypt? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Egypt

See all
Same topic, other categories

Related on genomics

See the topic